Nurix Therapeutics, Inc.

US$15.30As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NRIXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (3.71%)
Div yield —
ROE 43.99%
Biotechnology
Beta (5Y) 1.78
PE TTM 5.690
TSR TTM 18.24%
Mkt cap US$1.672B
ROIC 24.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$18
17.68%
(82.36%)
Hold 7|2|11|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.17
0.18
0.19
(2.48%)
0.50%
13.36%
11.94%
Revenue$M
91.00
90.04
88.01
85.40
3.69%
(0.98%)
(8.39%)
(8.89%)
Peers (US$1.672B)
Cap (US$)
PE
1.673B
—
Capital
TTM
5Y
10Y
Leveragex
0.649
0.589
0.424
EBIT/Intx
0.418
0.213
0.171
Own earn%
14.85
72.18
61.22
Sh yield%
49.35
39.05
38.97
Owners
Insiders/Inst%
3.37
65.77
Short interest%
1.20
SBC / revenue%
4.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
12–23
$1 testx
—
Incr. ROIC%
2